Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Potential of longitudinal data from single site and multi-center clinical trials for AI-research
Related Resources

Lung Cancer Screening in Germany: How mint Lesion Supports Hospitals with Infrastructure, Integration, and Scalability
Screening as a Strategic Challenge
With the launch of the national lung cancer screening program in 2026, hospitals and screening centers across…
Read more

AI-Supported Tumor Load Quantification for Bone Metastasis in Prostate Cancer
To assess treatment response in patients with advanced prostate cancer, radiologists rely on advanced medical imaging. Conventional modalities, such…
Read more

Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026
Read more